ML15107A465: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
Line 71: Line 71:
Conclusion I look forward to future coordination with your offices to ensure the continued protection of Federally listed species and designated critical habitats at the proposed SHINE site. If you have any questions regarding this letter, please contact Ms. Michelle Moser, Biologist, at  
Conclusion I look forward to future coordination with your offices to ensure the continued protection of Federally listed species and designated critical habitats at the proposed SHINE site. If you have any questions regarding this letter, please contact Ms. Michelle Moser, Biologist, at  


301-415-6509 or by e-mail at Michelle.Moser@nrc.gov
301-415-6509 or by e-mail at Michelle.Moser@nrc.gov. Sincerely,
. Sincerely,  
 
  /RA/
  /RA/
David J. Wrona, Chief Environmental Review and Guidance Branch      Division of License Renewal Office of Nuclear Reactor Regulation  
David J. Wrona, Chief Environmental Review and Guidance Branch      Division of License Renewal Office of Nuclear Reactor Regulation  
Line 89: Line 87:
==SUBJECT:==
==SUBJECT:==
AVAILABILITY OF THE DRAFT ENVIRONMENTAL IMPACT STATEMENT FOR THE CONSTRUCTION PERMIT FOR THE PROPOSED SHINE MEDICAL RADIOISOTOPE PRODUCTION FACILITY, AND THE U.S. NUCLEAR REGULATORY COMMISSION'S DETERMINATION THAT THE PROPOSED ACTION WOULD HAVE NO EFFECT ON FEDERALLY LISTED OR PROPOSED SPECIES OR CRITICAL HABITATS DISTRIBUTION:
AVAILABILITY OF THE DRAFT ENVIRONMENTAL IMPACT STATEMENT FOR THE CONSTRUCTION PERMIT FOR THE PROPOSED SHINE MEDICAL RADIOISOTOPE PRODUCTION FACILITY, AND THE U.S. NUCLEAR REGULATORY COMMISSION'S DETERMINATION THAT THE PROPOSED ACTION WOULD HAVE NO EFFECT ON FEDERALLY LISTED OR PROPOSED SPECIES OR CRITICAL HABITATS DISTRIBUTION:
E-MAIL: PUBLIC Public RTR r/f RidsNrrDpr  
E-MAIL: PUBLIC Public RTR r/f RidsNrrDpr  


RidsNrrDprPrta  
RidsNrrDprPrta  
Line 96: Line 94:


RidsOgcRp Resource RidsAcrsAcnw_MailCTR Resource ---------------------------------------------------
RidsOgcRp Resource RidsAcrsAcnw_MailCTR Resource ---------------------------------------------------
DHowe SLynch JLynch SHarwell MAdams CWeber CFrazier  
DHowe SLynch JLynch SHarwell MAdams CWeber CFrazier MConley MMoser DBarss LLondon JWeil AAdams ASapountzis MYoung VHuckabay LTran DSeymour TZaki DWrona Cc:  Jim Costedio Licensing Manager SHINE Medical Technologies, Inc.
 
MConley MMoser DBarss LLondon JWeil AAdams ASapountzis MYoung VHuckabay LTran DSeymour  
 
TZaki DWrona Cc:  Jim Costedio Licensing Manager SHINE Medical Technologies, Inc.
2555 Industrial Drive  
2555 Industrial Drive  


Line 107: Line 101:
Kirsten Cutler, Ph.D. National Security and International Affairs Office of Science and Technology Policy Executive Office Building  
Kirsten Cutler, Ph.D. National Security and International Affairs Office of Science and Technology Policy Executive Office Building  


1650 Pennsylvania Avenue Washington, DC 20503 Randy Howell National Nuclear Security Administration,  
1650 Pennsylvania Avenue Washington, DC 20503 Randy Howell National Nuclear Security Administration, NA-212 U.S. Department of Energy  1000 Independence Ave SW  Washington, DC 20585  
 
NA-212 U.S. Department of Energy  1000 Independence Ave SW  Washington, DC 20585  


Paul Schmidt  
Paul Schmidt  

Revision as of 05:42, 9 July 2018

Fws Letter for the Availability of the Shine Draft EIS
ML15107A465
Person / Time
Site: SHINE Medical Technologies
Issue date: 05/13/2015
From: Wrona D J
Division of License Renewal
To: Fasbender P J, Melius T
US Dept of Interior, Fish & Wildlife Service
Shared Package
ML15118A440 List:
References
DLR-15-0230
Download: ML15107A465 (6)


Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001

May 13, 2015

Mr. Tom Melius Regional Director U.S. Fish and Wildlife Service Midwest Region (Region 3) 5600 American Blvd. West, Suite 990

Bloomington, MN 55437-1458

Mr. Peter J. Fasbender Field Supervisor U.S. Fish and Wildlife Service Green Bay ES Field Office 2661 Scott Tower Drive New Franken, WI 54229

SUBJECT:

AVAILABILITY OF THE DRAFT ENVIRONMENTAL IMPACT STATEMENT FOR THE CONSTRUCTION PERMIT FOR THE PROPOSED SHINE MEDICAL RADIOISOTOPE PRODUCTION FACILITY, AND THE U.S. NUCLEAR REGULATORY COMMISSION'S DETERMINATION THAT THE PROPOSED ACTION WOULD HAVE NO EFFECT ON FEDERALLY LISTED OR PROPOSED SPECIES OR CRITICAL HABITATS

Dear Mr. Melius and Mr. Fasbender:

With this letter, the U.S. Nuclear Regulatory Commission (NRC; the staff) is forwarding you a copy of its draft Environmental Impact Statement (ElS) regarding the construction permit submitted by SHINE Medical Technology, Inc. (SHINE) for the proposed SHINE Medical Radioisotope Production Facility (SHINE facility), in accordance with the National Environmental

Policy Act of 1969, as amended (NEPA); Title 10, Part 51 of the Code of Federal Regulations (10 CFR Part 51); and the Endangered Species Act of 1973, as amended (ESA). This letter refers to the enclosed document as the draft "Environmental Impact Statement" (EIS).

The purpose of this letter is twofold: (1) to notify the U.S. Fish and Wildlife (FWS) that the NRC staff has determined that the proposed action would have no effect on Federally proposed or listed species, or proposed or designated critical habitat under FWS's jurisdiction, and (2) to provide FWS with information on the NEPA public comment period and associated public meetings for the draft EIS.

Project Summary

The SHINE facility, if licensed, would produce radioisotopes for use in diagnostic medical isotope procedures. The proposed location of this facility is approximately 4 miles south of the city center of Janesville, Rock County, Wisconsin. The proposed site would cover approximately 91 acres (37 hectare), which primarily consist of cultivated agricultural land; the remaining portion of the site includes some developed areas and open space. Due to the previous agricultural use at the proposed site, the site does not include forest, wetlands, T. Melius and

grasslands, or prairie habitats. In addition, no ephemeral, intermittent, or perennial streams and associated riparian zones are located within the boundaries of the proposed SHINE site.

The proposed Federal action is for the NRC to decide whether to issue a construction permit under 10 CFR Part 50 that would allow construction of a medical radioisotope production facility.

The NRC considered the potential impacts from construction, operations, and decommissioning in its analysis of effects to ESA-protected species and critical habitats.

The enclosed draft EIS addresses the environmental impacts of the proposed Federal action and alternatives. Chapter 3 of the enclosed draft EIS describes the affected environment, including terrestrial resources, aquatic resources, and ESA-protected species and critical habitats. Chapter 4 assesses impacts to these and other environmental resources. Chapter 5 assesses the environmental impacts of alternatives.

ESA "No Effect" Determination

As part of preparing the draft EIS, the NRC performed an assessment of whether the proposed action has the potential to adversely affect any Federally listed or proposed species or proposed or designated critical habitats. This assessment is documented in Sections 3.5, 4.5, and Appendix D of the draft EIS. The draft EIS fulfills the NRC's obligation to prepare a biological assessment under ESA section 7(c) and 50 CFR 402.12. Accordingly, the NRC did not prepare a separate biological assessment for the construction permit.

In Section 3.5 of the draft EIS, the NRC describes the action area and the ESA-protected species and critical habitats that have the potential to be present in the action area. This section includes information pursuant to 50 CFR 402.12(f)(1), (2), and (3). Section 4.5 of the draft EIS provides an assessment of the potential effects of the proposed action on the species and critical habitat present and the NRC's effect det erminations, which are consistent with those identified in Section 3.5 of the Endangered Species Consultation Handbook

1. The NRC also addresses cumulative effects and alternatives to the proposed action. This section includes information pursuant to 50 CFR 402.12(f)(4) and (5).

In Section 4.5, the NRC staff concludes that the proposed action would have no effect on any ESA-protected species or critical habitats. The NRC understands that FWS does not typically provide its concurrence with "no effect" determinations by Federal agencies 2 and that an agency's finding of "no effect" requires no further informal consultation or the initiation of formal

consultation. Nonetheless, because the draft EIS constitutes the NRC's biological assessment, the NRC staff is submitting a copy for your review in accordance with 50 CFR 402.12(j). The NRC welcomes any comments you may have on potential effects to ESA-protected species and critical habitats. Please let us know within 30 days from the date of receipt of this letter if you do not agree with the staff's "no effect" determination. You can submit your comments by letter directly to me or through the NEPA comment process described below. Should you need to 1 U.S. Fish and Wildlife Service and National Marine Fisheries Service. 1998. Endangered Species Consultation Handbook: Procedures for Conducting Consultation and Conference Activities Under Section 7 of the Endangered Species Act. March 1998. Washington, DC: U.S. Government Printing Office.

2 [FWS] U.S. Fish and Wildlife Service. 2013. "Consultations: Frequently Asked Questions." Available at

<http://www.fws.gov/endangered/what-we-do/faq.html

>.

T. Melius and

discuss the project before making a determination, please contact Michelle Moser of my staff. Ms. Moser's contact information is below.

NEPA Comment Period and Public Meetings

Pursuant to NEPA, the NRC is seeking comments on the draft EIS through July 6, 2015. During the comment period, the NRC staff plans to hold two public environmental meetings at the Rotary Botanical Gardens, 1455 Palmer Drive, Janesville, WI 53545, on June 10, 2015, from 2:00 p.m. until 4:00 p.m. and from 7:00 p.m. until 9:00 p.m. The meetings will be transcribed and will include a presentation of the contents of the draft EIS and the opportunity for interested government agencies, organizations, and individuals to provide comments on the draft report. I invite you and your staff to attend the public meetings and to submit comments on the draft EIS. See the enclosed Federal Register notice or go to http://www.Regulations.gov and search for documents filed under Docket ID NRC-2013-0053 for additional information on the NEPA process and on how to submit comments.

Conclusion I look forward to future coordination with your offices to ensure the continued protection of Federally listed species and designated critical habitats at the proposed SHINE site. If you have any questions regarding this letter, please contact Ms. Michelle Moser, Biologist, at

301-415-6509 or by e-mail at Michelle.Moser@nrc.gov. Sincerely,

/RA/

David J. Wrona, Chief Environmental Review and Guidance Branch Division of License Renewal Office of Nuclear Reactor Regulation

Docket No. 50-608

Enclosures:

1. Draft EIS
2. Federal Register Notice

cc w/encl: See next page

ML15118A440 (Pkg), ML15107A465 (Ltr), ML15105A291 (FRN), ML15127A241 (Draft EIS) *concurred via email Letter to Tom Melius and Peter Fasbender from David Wrona dated May 13, 2015

SUBJECT:

AVAILABILITY OF THE DRAFT ENVIRONMENTAL IMPACT STATEMENT FOR THE CONSTRUCTION PERMIT FOR THE PROPOSED SHINE MEDICAL RADIOISOTOPE PRODUCTION FACILITY, AND THE U.S. NUCLEAR REGULATORY COMMISSION'S DETERMINATION THAT THE PROPOSED ACTION WOULD HAVE NO EFFECT ON FEDERALLY LISTED OR PROPOSED SPECIES OR CRITICAL HABITATS DISTRIBUTION:

E-MAIL: PUBLIC Public RTR r/f RidsNrrDpr

RidsNrrDprPrta

RidsNrrDprPrtb

RidsOgcRp Resource RidsAcrsAcnw_MailCTR Resource ---------------------------------------------------

DHowe SLynch JLynch SHarwell MAdams CWeber CFrazier MConley MMoser DBarss LLondon JWeil AAdams ASapountzis MYoung VHuckabay LTran DSeymour TZaki DWrona Cc: Jim Costedio Licensing Manager SHINE Medical Technologies, Inc.

2555 Industrial Drive

Monona, WI 53713

Kirsten Cutler, Ph.D. National Security and International Affairs Office of Science and Technology Policy Executive Office Building

1650 Pennsylvania Avenue Washington, DC 20503 Randy Howell National Nuclear Security Administration, NA-212 U.S. Department of Energy 1000 Independence Ave SW Washington, DC 20585

Paul Schmidt

Manager Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659

Madison, WI 53701-2659

Laura Bub Environmental Analysis and Review Specialist State of Wisconsin Department of Natural Resources 3911 Fish Hatchery Road Fitchburg, WI 53711 TRTR Newsletter University of Florida Department of Nuclear Engineering Sciences 202 Nuclear Sciences Center Gainesville, FL 32611

Mark Freitag City Manager P.O. Box 5005 Janesville, WI 53547-5005

Bill McCoy

1326 Putnam Avenue Janesville, WI 53546 Alfred Lembrich

541 Miller Avenue Janesville, WI 53548

Gerald and Muriel Bumgarner 1735 S Osborne Avenue Janesville, WI 53546